Cargando…

Molecular markers that predict response to combined radiotherapy and immunotherapy in patients with lung adenocarcinoma: a bioinformatics analysis

BACKGROUND: Immunotherapy has had a high success rate in treating lung adenocarcinoma (LUAD) for several decades. However, many patients do not benefit from immunotherapy alone. Recent studies revealed that a combination of immunotherapy and radiotherapy (RT) stimulates a good systemic immune respon...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Lu, Zhou, Haiting, Wu, Cheng, Peng, Yi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10643968/ https://www.ncbi.nlm.nih.gov/pubmed/37969379 http://dx.doi.org/10.21037/tcr-23-968

Ejemplares similares

Bioinformatics construction and experimental validation of a cuproptosis-related lncRNA prognostic model in lung adenocarcinoma for immunotherapy response prediction
por: Li, Linfeng, et al.
Publicado: (2023)

A bioinformatics-based immune-related prognostic index for lung adenocarcinoma that predicts patient response to immunotherapy and common treatments
por: Wang, Chenghao, et al.
Publicado: (2022)

Cuproptosis Depicts Immunophenotype and Predicts Immunotherapy Response in Lung Adenocarcinoma
por: Zhou, Wolong, et al.
Publicado: (2023)

Tumor stemness and immune infiltration synergistically predict response of radiotherapy or immunotherapy and relapse in lung adenocarcinoma
por: Shi, Hongjie, et al.
Publicado: (2021)

Identification of Radiotherapy-Associated Genes in Lung Adenocarcinoma by an Integrated Bioinformatics Analysis Approach
por: Wang, Junhao, et al.
Publicado: (2021)

Gene signature based on B cell predicts clinical outcome of radiotherapy and immunotherapy for patients with lung adenocarcinoma
por: Han, Linzhi, et al.
Publicado: (2020)

DNA methylation profiling in early lung adenocarcinoma to predict response to immunotherapy
por: De Smet, Charles
Publicado: (2023)

Hepatoid Adenocarcinoma of the Lung Responsive to Frontline Combination Chemotherapy With Immunotherapy: Case Report
por: Lagos, Galina G., et al.
Publicado: (2020)

Bioinformatics analysis combined with experiments predicts CENPK as a potential prognostic factor for lung adenocarcinoma
por: Ma, Jiayu, et al.
Publicado: (2021)

The Combination of Radiotherapy With Immunotherapy and Potential Predictive Biomarkers for Treatment of Non-Small Cell Lung Cancer Patients
por: Meng, Lu, et al.
Publicado: (2021)

Combining immunotherapy and radiotherapy in lung cancer: a promising future?
por: Zhou, Jieling, et al.
Publicado: (2020)

Extracranial abscopal effect induced by combining immunotherapy with brain radiotherapy in a patient with lung adenocarcinoma: A case report and literature review
por: Lin, Xinqing, et al.
Publicado: (2019)

Identification of potential key molecular biomarkers in lung adenocarcinoma by bioinformatics analysis
por: Guo, Pengyi, et al.
Publicado: (2022)

Identification and Validation of the Pyroptosis-Related Molecular Subtypes of Lung Adenocarcinoma by Bioinformatics and Machine Learning
por: Liu, Le-Ping, et al.
Publicado: (2021)

Evaluating the Combined Anticancer Response of Checkpoint Inhibitor Immunotherapy and FAP-Targeted Molecular Radiotherapy in Murine Models of Melanoma and Lung Cancer
por: Capaccione, Kathleen M., et al.
Publicado: (2022)

Identification of CDT1 as a prognostic marker in human lung adenocarcinoma using bioinformatics approaches
por: Jiang, Jing, et al.
Publicado: (2023)

Immunogenic cell death-based prognostic model for predicting the response to immunotherapy and common therapy in lung adenocarcinoma
por: Zhou, Xiang, et al.
Publicado: (2023)

A cuproptosis-related lncRNA signature for predicting prognosis and immunotherapy response of lung adenocarcinoma
por: Yu, Sheng, et al.
Publicado: (2023)

Successful treatment of induced oligometastasis and repeated oligoprogression of advanced lung adenocarcinoma with immunotherapy and radiotherapy
por: Lee, Ho Young, et al.
Publicado: (2022)

Molecular subtyping based on immune cell marker genes predicts prognosis and therapeutic response in patients with lung adenocarcinoma
por: Liu, Zi-Tao, et al.
Publicado: (2023)

Radiotherapy and Immunotherapy in Lung Cancer
por: Hsieh, Kristin, et al.
Publicado: (2023)

An integrated bioinformatic analysis of bulk and single-cell sequencing clarifies immune microenvironment and metabolic profiles of lung adenocarcinoma to predict immunotherapy efficacy
por: Li, Mengling, et al.
Publicado: (2023)

SETD2 mediates immunotherapy and radiotherapy efficacy via regulating DNA damage responses and genomic stability in lung adenocarcinoma
por: Zeng, Zihang, et al.
Publicado: (2022)

Combination of immunotherapy with chemotherapy and radiotherapy in lung cancer: is this the beginning of the end for cancer?
por: Lazzari, Chiara, et al.
Publicado: (2018)

Identification of significant genes as prognostic markers and potential tumor suppressors in lung adenocarcinoma via bioinformatical analysis
por: Lu, Mingze, et al.
Publicado: (2021)

Prognostic model and immunotherapy prediction based on molecular chaperone-related lncRNAs in lung adenocarcinoma
por: Xu, Yue, et al.
Publicado: (2022)

Development of cancer-associated fibroblast-related gene signature for predicting the survival and immunotherapy response in lung adenocarcinoma
por: Zhang, Yong, et al.
Publicado: (2023)

Prediction of prognosis and immunotherapy response in lung adenocarcinoma based on CD79A, DKK1 and VEGFC
por: Zhang, Qilong, et al.
Publicado: (2023)

Immunotherapy response and microenvironment provide biomarkers of immunotherapy options for patients with lung adenocarcinoma
por: Zhan, Xue, et al.
Publicado: (2022)

Immunotherapy efficacy predictive tool for lung adenocarcinoma based on neural network
por: Li, Wei, et al.
Publicado: (2023)

A Pyroptosis-Related Signature Predicts Overall Survival and Immunotherapy Responses in Lung Adenocarcinoma
por: Zhu, Kaibin, et al.
Publicado: (2022)

A Metabolism-Related Gene Prognostic Index for Prediction of Response to Immunotherapy in Lung Adenocarcinoma
por: Tang, Bo, et al.
Publicado: (2022)

APOBEC mutational signature predicts prognosis and immunotherapy response in nonsmoking patients with lung adenocarcinoma
por: Ma, Jianli, et al.
Publicado: (2023)

Cuproptosis and Immune-Related Gene Signature Predicts Immunotherapy Response and Prognosis in Lung Adenocarcinoma
por: Sun, Zihao, et al.
Publicado: (2023)

Exploring the potential mechanism of emetine against coronavirus disease 2019 combined with lung adenocarcinoma: bioinformatics and molecular simulation analyses
por: Zhang, Kun, et al.
Publicado: (2022)

Radiotherapy–immunotherapy combinations – perspectives and challenges
por: Mondini, Michele, et al.
Publicado: (2020)

Combinations of radiotherapy with immunotherapy in cervical cancer
por: Yang, Xiaojing, et al.
Publicado: (2022)

Mechanistic rationales for combining immunotherapy with radiotherapy
por: Chi, Alexander, et al.
Publicado: (2023)

Potential Prognostic Biomarkers of Lung Adenocarcinoma Based on Bioinformatic Analysis
por: Hou, Jili, et al.
Publicado: (2021)

A novel immune-related ceRNA network that predicts prognosis and immunotherapy response in lung adenocarcinoma
por: Gong, Wei-Jing, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1j9s9h77j2m39b25m3f1a00ske